The zebrafish (Danio rerio) is an alluring model system currently used to study early embryonic development, organogenesis and gene functional analysis. However, few studies have been devoted to post-embryonic development. We have explored the possibility of using this organism to analyze how cranial suture patterning occurs. This study reports on the establishment of the zebrafish skull vault anatomy, calvarial osteogenesis, and cranial suture morphology. Our results demonstrate that the anatomy of the zebrafish cranial vault and cranial sutures is very similar to that of mammalian organisms. Indeed, the zebrafish represents a versatile and valuable model system for the study of the biogenesis of cranial sutures.

1.
Ahlberg, P.E., A.R. Milner (1994) The origin and early diversification of tetrapods. Nature 368: 507–514.
2.
Couly, G.F., P.M. Coltey, N. Le Douarin (1993) The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development 117: 409–429.
3.
Cubbage, C.C., P.M. Mabee (1996) Development of the cranium and paired fins in the zebrafish Danio rerio (Ostariophysi, Cyprinidae). J Morph 229: 121–160.
4.
Driever, W., M.C. Fishman (1996) The zebrafish: heritable disorders in transparent embryos. J Clin Invest 97: 1788–1794.
5.
Driever, W., L. Solnica-Krezel, A.F. Schier, S.C. Neuhauss, J. Malicki, D.L. Stemple, D.Y. Stainier, F. Zwartkruis, S. Abdelilah, Z. Rangini, J. Belak, C. Boggs (1996) A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123: 37–46.
6.
Finley, K.R., A.E. Davidson, S. Ekker (2001) Three-color imaging using fluorescent proteins in living zebrafish embryos. Biotechniques 31: 66–72.
7.
Haffter, P., M. Granato, M. Brand, M.C. Mullins, M. Hammerschmidt, D.A. Kane, J. Odenthal, F.J. van Eeden, Y.J. Jiang, C.P. Heisenberg, R.N. Kelsh, M. Furutani-Seiki, E. Vogelsang, D. Beuchle, U. Schach, C. Fabian, C. Nüsslein-Volhard (1996) The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123: 1–36.
8.
Hehr, U., M. Muenke (1999) Craniosynostosis syndromes: from genes to premature fusion of skull bones. Mol Genet Metab 68: 139–151.
9.
Jiang, X., S. Iseki, R. Maxson, H.M. Sucov, G.M. Morris-Kay (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biol 241: 106–116.
10.
Johansen, V.A., S.H. Hall (1982) Morphogenesis of the mouse coronal suture. Acta Anat 114: 58–67.
11.
Kimmel, C.B., W.W. Ballard, S.R. Kimmel, B. Ullmann, T.F. Schilling (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253–310.
12.
Mathijssen, I.M.J., J. van Splunder, Chr. Vermeij-Keers, H. Pieterman, T.H.R. de Jong, M.P. Mooney, J.M. Vaandrager (1999) Tracing craniosynostosis to its developmental stage through bone center displacement. J Craniofac Genet Dev Biol 19: 57–63.
13.
Morris-Kay, G.M. (2001) Derivation of the mammalian skull vault. J Anat 199: 143–151.
14.
Neuhauss, S.C., L. Solnica-Krezel, A. Schier, F. Zwartkruis, D.L. Stemple, J. Malicki, S. Abdelilah, D.Y. Stainier, W. Driever (1996) Mutations affecting craniofacial development in zebrafish. Development 123: 357–367.
15.
Noden, D.M. (1984) Craniofacial development: new views on old problems. Anat Rec 208: 1–13.
16.
Opperman, L.A. (2000) Cranial sutures as intramembranous bone growth sites. Dev Dyn 219: 472–485.
17.
Piotrowski, T., C. Nüsslein-Volhard (2000) The endoderm plays an important role in patterning the segmented pharyngeal region in zebrafish (Danio rerio). Dev Biol 225: 339–356.
18.
Postlethwait, J.H., Y.L. Yan, M.A. Gates, S. Horne, A. Amores, A. Brownlie, A. Donovan, E.S. Egan, A. Force, Z. Gong, C. Goutel, A. Fritz, R. Kelsch, E. Knapik, E. Liao, B. Paw, D. Ransom, A. Singer, M. Thomson, T.S. Abduljabbar, P. Yelick, D. Beier, J.S. Joly, D. Larhammar, F. Rosa, M. Westerfield, L.I. Zon, S.L. Johnson, W.S. Talbot (1998) Vertebrate genome evolution and zebrafish gene map. Nat Genet 18: 345–349.
19.
Postlethwait, J.H., W.S. Talbot (1997) Zebrafish genomics: from mutants to genes. Trends Genet 13: 183–189.
20.
Schilling, T.F. (1997) Genetic analysis of craniofacial development in the vertebrate embryo. Bioessays 19: 459–468.
21.
Schilling, T.H., C.B. Kimmel (1994) Segment and cell type lineage restrictions during pharyngeal arch development in the zebrafish embryo. Development 120: 483–490.
22.
Shapiro, R., F. Robinson (1980) The Embryogenesis of the Human Skull. An Anatomic andRadiographic Atlas. Cambridge, Harvard University Press.
23.
Talbot, W.S., N. Hopkins (2000) Zebrafish mutations and functional analysis of the vertebrate genome. Genes Dev 14: 755–762.
24.
Ward, A.C., G.J. Lieschke (2002) The zebrafish as a model system for human disease. Front Biosci 7: 827–833.
25.
Westerfield, M. (2000) The Zebrafish Book, ed 4. Eugene, University of Oregon Press.
26.
Wilkie, A.O. (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6: 1647–1656.
27.
Wilkie, A.O., S.A. Wall (1996) Craniosynostosis: novel insights into pathogenesis and treatment. Curr Opin Neurol 9: 146–152.
28.
Wirchow, R. (1956) Standpoint in scientific medicine, 1877. Bull Hist Med 6: 537–543.
29.
Zimmermann, B., A. Moegelin, P. de Souza, J. Bier (1998) Morphology of the development of the sagittal suture of mice. Anat Embryol 197: 155–165.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.